Glycine

Glycine

SCHEMBL8627103

NCC(=O)[O-].NCC(=O)[O-].NCC(=O)[O-].NCC(=O)[O-].[Al+3].[Na+]

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADORA1ADORA2AADORA2BADORA3PDE3APDE3BPDE4APDE4BPDE4CPDE4D

The experimentally established mechanism targets of Glycine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CA4 P22748 5/20 0.50
CASP1 P29466 1/20 0.47
GLRA1 P23415 1/20 0.44
SLC6A9 P48067 1/20 0.44
OR51E2 Q9H255 1/20 0.44
MEN1 O00255 1/20 0.41
LDHA P00338 1/20 0.41
BLM P54132 1/20 0.41
KMT2A Q03164 1/20 0.41
FFAR3 O14843 2/20 0.40
HDAC3 O15379 2/20 0.40
HDAC1 Q13547 2/20 0.40
HDAC2 Q92769 2/20 0.40
HDAC8 Q9BY41 2/20 0.40
FAHD1 Q6P587 1/20 0.40
CA2 P00918 1/20 0.38
CA1 P00915 3/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Glycine SCHEMBL223345 0.96 CA4 (0.47) CA4CASP1GLRA1SLC6A9OR51E2
Glycine SCHEMBL2184513 0.96 CA4 (0.53) CA4CASP1GLRA1SLC6A9OR51E2
Glycine SCHEMBL27196 0.96
Glycine SCHEMBL10725312 0.96 CA4 (0.53) CA4CASP1GLRA1SLC6A9OR51E2
Glycine SCHEMBL3205805 0.92
Glycine SCHEMBL5187484 0.92 CA4 (0.44) CA4CASP1GLRA1SLC6A9OR51E2
Glycine SCHEMBL5943682 0.92 CA4 (0.44) CA4CASP1GLRA1SLC6A9OR51E2
Glycine SCHEMBL2405749 0.92
Glycine SCHEMBL3121145 0.92 CA4 (0.44) CA4CASP1GLRA1SLC6A9OR51E2
Glycine SCHEMBL2161269 0.92 CA4 (0.44) CA4CASP1GLRA1SLC6A9OR51E2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5723453-A Stabilized, water-soluble aspirin composition HEALTH CORPORATION (US) 1998-03-03 US disclosed
US-5157030-A Adding lecithin polysorbate, glycerol monostearate, or polyether surfactant SOLUPRIN PHARMACEUTICALS, INC. 1992-10-20 US disclosed